fda glp-1 warning letters november 2025 warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain Beyond the Headlines: FDA Warning

He noted Highmark has hired 1,800 new associates year-to-date

Unsupervised "off-label" use, particularly for quick cosmetic weight loss, bypassing specialist oversight, can lead to severe and life-threatening side effects

In the RCT (exenatide), patients on acetazolamide were excluded to better isolate the effect of exenatide during the 12-week trial period [14, 35]

A survey conducted in August found that more than 80% of Americans had heard at least a little bit about semaglutide, while about one-third had either tried it or expressed interest in doing so

Due to this shortage, pharmaceutical manufacturers have created compounded versions of Ozempic and Wegovy

When its blood supply is compromised, it can lead to significant visual impairment